| OCR Text |
Show From: University of Utah Law To: LAW All Library DL Subject: The Future of Gene Patenting Date: Friday, October 25, 2013 9:46:22 AM Having trouble viewing this email? View it in your browser A Delicate Balance of Innovation and Access: The Future of Gene Patenting after Association forMolecular Pathology, et al. v. Myriad Genetics, Inc. et al. Friday, November 1, 2013 12:15-3:00 p.m., Sutherland Moot Courtroom, S.J. Quinney College of LawIn June 2013, the United States Supreme Court invalidated some but not all of the patents ontwo genes implicated in breast cancer. The 9-0 ruling in Association for Molecular Pathology, etal. v. Myriad Genetics, Inc. et al. is the Court's seminal statement on human gene patenting.Understanding what the decision means for the future of gene patenting is thus critical foranyone interested in the isolation of genetic variants, genetic testing, commercialization, andpersonalized medicine and patient care. This event will discuss in depth the science involved inthe Myriad decision, the decision's holding, its implications for industry, and its likely impact ongenetic testing in clinical care. Panelists include scientists, lawyers, genetic counselors, andpatient advocates. Read more >> Lunch provided. 2.5 hours of CLE (approval pending). Free and open to the public.Registration requested >> Watch this event live on ULaw.tv >>Sponsored by the Center for Law and Biomedical Sciences at the S.J. Quinney Collegeof Law and the Health Law Section of the Utah State Bar. Limited meter parking available in the College of Law parking lot. Free parking available atRice-Eccles Stadium or take TRAX University Line to the Stadium stop and walk a half block tothe north. 332 South 1400 EastSalt Lake City, UT 84112 Stay Connected! Facebook | Twitter | LinkedIn |
